ARTICLE | Clinical News
CAT 310: Phase Ib started
February 9, 2009 8:00 AM UTC
The companies began an open-label, Canadian Phase Ib trial in healthy volunteers to evaluate oral CAT 310 vs. Marinol dronabinol from Solvay S.A. (Euronext:SOLB, Brussels, Belgium). Cannasat and Int...